Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Posternak

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
The Journal of Nervous and Mental Disease|May 16, 2006
The naturalistic course of unipolar major depression in the absence of somatic therapyMichael A Posternak, David A Solomon, Andrew C Leon, et al.
The American Journal of Psychiatry|July 2, 2004
Which factors influence psychiatrists' selection of antidepressants?Mark Zimmerman, Michael Posternak, Michael Friedman, et al.
Human Gene Therapy|June 18, 2002
Clinical protocol. A phase II study: efficacy of the gene therapy of the MVA E2 recombinant virus in the treatment of precancerous lesions (NIC I and NIC II) associated with infection of oncogenic human papillomavirusCarlos Manual Corona Gutierrez, Alberto Tinoco, Mario López Contreras, et al.
International Clinical Psychopharmacology|December 19, 2008
Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studiesGeorge I Papakostas, Rena Cooper-Kazaz, Bente C Appelhof, et al.
Molecular Immunology|April 18, 2006
Mapping and molecular characterization of novel monoclonal antibodies to conformational epitopes on NH2 and COOH termini of mammalian tryptophanyl-tRNA synthetase reveal link of the epitopes to aggregation and Alzheimer's diseaseElena L Paley, Larisa Smelyanski, Vladimir Malinovskii, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|January 26, 2006
A description of next-step switching versus augmentation practices for outpatients with treatment-resistant major depressive disorder enrolled in an academic specialty clinicGeorge I Papakostas, Timothy J Petersen, Cassandra Green, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|June 29, 2022
Smooth versus textured tissue expanders in breast reconstruction - A retrospective review of post-operative surgical site infectionsRuth Tevlin, Sophie L Cemaj, Amee D Azad, et al.
Journal of Clinical Psychopharmacology|July 14, 2005
Empirical testing of two models for staging antidepressant treatment resistanceTimothy Petersen, George I Papakostas, Michael A Posternak, et al.
The Journal of Nervous and Mental Disease|February 24, 2001
A brief assessment of psychosocial functioning of subjects with bipolar I disorder: the LIFE-RIFT. Longitudinal Interval Follow-up Evaluation-Range Impaired Functioning ToolA C Leon, D A Solomon, T I Mueller, et al.
The Journal of Clinical Psychiatry|March 16, 2005
Tachyphylaxis in unipolar major depressive disorderDavid A Solomon, Andrew C Leon, Timothy I Mueller, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
The Journal of Nervous and Mental Disease|May 16, 2006
The naturalistic course of unipolar major depression in the absence of somatic therapyMichael A Posternak, David A Solomon, Andrew C Leon, et al.
The American Journal of Psychiatry|July 2, 2004
Which factors influence psychiatrists' selection of antidepressants?Mark Zimmerman, Michael Posternak, Michael Friedman, et al.
Human Gene Therapy|June 18, 2002
Clinical protocol. A phase II study: efficacy of the gene therapy of the MVA E2 recombinant virus in the treatment of precancerous lesions (NIC I and NIC II) associated with infection of oncogenic human papillomavirusCarlos Manual Corona Gutierrez, Alberto Tinoco, Mario López Contreras, et al.
International Clinical Psychopharmacology|December 19, 2008
Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studiesGeorge I Papakostas, Rena Cooper-Kazaz, Bente C Appelhof, et al.
Molecular Immunology|April 18, 2006
Mapping and molecular characterization of novel monoclonal antibodies to conformational epitopes on NH2 and COOH termini of mammalian tryptophanyl-tRNA synthetase reveal link of the epitopes to aggregation and Alzheimer's diseaseElena L Paley, Larisa Smelyanski, Vladimir Malinovskii, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|January 26, 2006
A description of next-step switching versus augmentation practices for outpatients with treatment-resistant major depressive disorder enrolled in an academic specialty clinicGeorge I Papakostas, Timothy J Petersen, Cassandra Green, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|June 29, 2022
Smooth versus textured tissue expanders in breast reconstruction - A retrospective review of post-operative surgical site infectionsRuth Tevlin, Sophie L Cemaj, Amee D Azad, et al.
Journal of Clinical Psychopharmacology|July 14, 2005
Empirical testing of two models for staging antidepressant treatment resistanceTimothy Petersen, George I Papakostas, Michael A Posternak, et al.
The Journal of Nervous and Mental Disease|February 24, 2001
A brief assessment of psychosocial functioning of subjects with bipolar I disorder: the LIFE-RIFT. Longitudinal Interval Follow-up Evaluation-Range Impaired Functioning ToolA C Leon, D A Solomon, T I Mueller, et al.
The Journal of Clinical Psychiatry|March 16, 2005
Tachyphylaxis in unipolar major depressive disorderDavid A Solomon, Andrew C Leon, Timothy I Mueller, et al.
Pageof 15